IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients.

ABSTRACT:

Background

Most people who make the transition to renal replacement therapy (RRT) are treated with a fixed dose thrice-weekly hemodialysis réegimen, without considering their residual kidney function (RKF). Recent papers inform us that incremental hemodialysis is associated with preservation of RKF, whenever compared with conventional hemodialysis. The objective of the present controlled randomized trial (RCT) is to determine if start HD with one sessions per week (1-Wk/HD), it is associated with better patient survival and other safety parameters.

Methods/design

IHDIP is a multicenter RCT experimental open trial. It is randomized in a 1:1 ratio and controlled through usual clinical practice, with a low intervention level and non-commercial. It includes 152 incident patients

SUBMITTER: Deira J 

PROVIDER: S-EPMC6325813 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature